Shared Content

SCOTUS Analysis of Hikma v. Amarin and SG Certiorari Outlook

Content may be unverified or unsafe. Report

Citations

June 24th 2024 - Federal Court Appeals Win.pdf

file://file-6UNSvArmsauBHGkfPcRSXo

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

June 24th 2024 - Federal Court Appeals Win.pdf

file://file-6UNSvArmsauBHGkfPcRSXo

June 24th 2024 - Federal Court Appeals Win.pdf

file://file-6UNSvArmsauBHGkfPcRSXo

June 24th 2024 - Federal Court Appeals Win.pdf

file://file-6UNSvArmsauBHGkfPcRSXo

June 24th 2024 - Federal Court Appeals Win.pdf

file://file-6UNSvArmsauBHGkfPcRSXo

June 24th 2024 - Federal Court Appeals Win.pdf

file://file-6UNSvArmsauBHGkfPcRSXo

June 24th 2024 - Federal Court Appeals Win.pdf

file://file-6UNSvArmsauBHGkfPcRSXo

June 24th 2024 - Federal Court Appeals Win.pdf

file://file-6UNSvArmsauBHGkfPcRSXo

October 17th 2024 - en banc denied.pdf

file://file-NqFUxLE1ViW1UFXUQamgdC

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Jun 2nd 2025 - Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. (Distributed).pdf

file://file-UZ373xim72wDnxgy5g8noE

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

June 24th 2024 - Federal Court Appeals Win.pdf

file://file-6UNSvArmsauBHGkfPcRSXo

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

June 24th 2024 - Federal Court Appeals Win.pdf

file://file-6UNSvArmsauBHGkfPcRSXo

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

May 15th 2025 - Brief of respondents Amarin Pharma, Inc., et al. in opposition filed..pdf

file://file-58X4GftHQtQuoKvbh7mPWr

Jun 2nd 2025 - Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. (Distributed).pdf

file://file-UZ373xim72wDnxgy5g8noE

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

Jun 2nd 2025 - Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. (Distributed).pdf

file://file-UZ373xim72wDnxgy5g8noE

Jun 2nd 2025 - Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. (Distributed).pdf

file://file-UZ373xim72wDnxgy5g8noE

Jun 2nd 2025 - Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. (Distributed).pdf

file://file-UZ373xim72wDnxgy5g8noE

Docket for 24-889 - Supreme Court

https://www.supremecourt.gov/docket/docketfiles/html/public/24-889.html

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

March 20th 2025 - Brief amici curiae of 30 Scholars of Law,.pdf

file://file-LVvvQi9MUoWK83KvB3HUpL

March 20th 2025 - Brief amici curiae of 30 Scholars of Law,.pdf

file://file-LVvvQi9MUoWK83KvB3HUpL

March 20th 2025 - Brief amici curiae of 30 Scholars of Law,.pdf

file://file-LVvvQi9MUoWK83KvB3HUpL

March 20th 2025 - Brief amici curiae of 30 Scholars of Law,.pdf

file://file-LVvvQi9MUoWK83KvB3HUpL

March 20th 2025 - Brief amici curiae of 30 Scholars of Law,.pdf

file://file-LVvvQi9MUoWK83KvB3HUpL

March 20th 2025 - Brief amici curiae of 30 Scholars of Law,.pdf

file://file-LVvvQi9MUoWK83KvB3HUpL

March 20th 2025 - Brief amici curiae of 30 Scholars of Law,.pdf

file://file-LVvvQi9MUoWK83KvB3HUpL

March 20th 2025 - Brief amici curiae of 30 Scholars of Law,.pdf

file://file-LVvvQi9MUoWK83KvB3HUpL

March 20th 2025 - Brief amici curiae of 30 Scholars of Law,.pdf

file://file-LVvvQi9MUoWK83KvB3HUpL

March 20th 2025 - Brief amici curiae of 30 Scholars of Law,.pdf

file://file-LVvvQi9MUoWK83KvB3HUpL

March 20th 2025 - Brief amici curiae of 30 Scholars of Law,.pdf

file://file-LVvvQi9MUoWK83KvB3HUpL

SCOTUS won’t hear Teva v. GSK: Where does that leave us on FDA labeling carve-outs?

https://www.hoganlovells.com/en/publications/scotus-wont-hear-teva-v-gsk-where-does-that-leave-us-on-fda-labeling-carve-outs

SCOTUS won’t hear Teva v. GSK: Where does that leave us on FDA labeling carve-outs?

https://www.hoganlovells.com/en/publications/scotus-wont-hear-teva-v-gsk-where-does-that-leave-us-on-fda-labeling-carve-outs

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

SCOTUS won’t hear Teva v. GSK: Where does that leave us on FDA labeling carve-outs?

https://www.hoganlovells.com/en/publications/scotus-wont-hear-teva-v-gsk-where-does-that-leave-us-on-fda-labeling-carve-outs

SCOTUS won’t hear Teva v. GSK: Where does that leave us on FDA labeling carve-outs?

https://www.hoganlovells.com/en/publications/scotus-wont-hear-teva-v-gsk-where-does-that-leave-us-on-fda-labeling-carve-outs

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

SCOTUS won’t hear Teva v. GSK: Where does that leave us on FDA labeling carve-outs?

https://www.hoganlovells.com/en/publications/scotus-wont-hear-teva-v-gsk-where-does-that-leave-us-on-fda-labeling-carve-outs

SCOTUS won’t hear Teva v. GSK: Where does that leave us on FDA labeling carve-outs?

https://www.hoganlovells.com/en/publications/scotus-wont-hear-teva-v-gsk-where-does-that-leave-us-on-fda-labeling-carve-outs

Will the Supreme Court save lower-cost medications from inducement by skinny labels? — Markman Advisors

https://www.markmanadvisors.com/blog/2025/6/26/will-the-supreme-court-save-lower-cost-medications-from-inducement-by-skinny-labels

Will the Supreme Court save lower-cost medications from inducement by skinny labels? — Markman Advisors

https://www.markmanadvisors.com/blog/2025/6/26/will-the-supreme-court-save-lower-cost-medications-from-inducement-by-skinny-labels

Feb 14 2025 - Hikma writ of writ of certiorari.pdf

file://file-6PcGz8NhJv9VL1P4jDNoFd

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s Teva v. GSK Decision | Biosimilars Law Bulletin

https://www.biosimilarsip.com/2023/04/18/solicitor-general-urges-the-supreme-court-to-reverse-the-federal-circuits-teva-v-gsk-decision/

Docket for 24-889 - Supreme Court

https://www.supremecourt.gov/docket/docketfiles/html/public/24-889.html

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

Will the Supreme Court save lower-cost medications from inducement by skinny labels? — Markman Advisors

https://www.markmanadvisors.com/blog/2025/6/26/will-the-supreme-court-save-lower-cost-medications-from-inducement-by-skinny-labels

Will the Supreme Court save lower-cost medications from inducement by skinny labels? — Markman Advisors

https://www.markmanadvisors.com/blog/2025/6/26/will-the-supreme-court-save-lower-cost-medications-from-inducement-by-skinny-labels

June 24th 2024 - Federal Court Appeals Win.pdf

file://file-6UNSvArmsauBHGkfPcRSXo

June 24th 2024 - Federal Court Appeals Win.pdf

file://file-6UNSvArmsauBHGkfPcRSXo

Will the Supreme Court save lower-cost medications from inducement by skinny labels? — Markman Advisors

https://www.markmanadvisors.com/blog/2025/6/26/will-the-supreme-court-save-lower-cost-medications-from-inducement-by-skinny-labels

Will the Supreme Court save lower-cost medications from inducement by skinny labels? — Markman Advisors

https://www.markmanadvisors.com/blog/2025/6/26/will-the-supreme-court-save-lower-cost-medications-from-inducement-by-skinny-labels

Will the Supreme Court save lower-cost medications from inducement by skinny labels? — Markman Advisors

https://www.markmanadvisors.com/blog/2025/6/26/will-the-supreme-court-save-lower-cost-medications-from-inducement-by-skinny-labels

March 21st 2025 - Brief amicus curiae of Association for Accessible Medicines.pdf

file://file-HTMyc9KZogMKhxQUJxW3fo

Will the Supreme Court save lower-cost medications from inducement by skinny labels? — Markman Advisors

https://www.markmanadvisors.com/blog/2025/6/26/will-the-supreme-court-save-lower-cost-medications-from-inducement-by-skinny-labels

Will the Supreme Court save lower-cost medications from inducement by skinny labels? — Markman Advisors

https://www.markmanadvisors.com/blog/2025/6/26/will-the-supreme-court-save-lower-cost-medications-from-inducement-by-skinny-labels

Will the Supreme Court save lower-cost medications from inducement by skinny labels? — Markman Advisors

https://www.markmanadvisors.com/blog/2025/6/26/will-the-supreme-court-save-lower-cost-medications-from-inducement-by-skinny-labels

Will the Supreme Court save lower-cost medications from inducement by skinny labels? — Markman Advisors

https://www.markmanadvisors.com/blog/2025/6/26/will-the-supreme-court-save-lower-cost-medications-from-inducement-by-skinny-labels

All Sources